Glutamate receptor subunit GluR2 and NMDAR1 immunoreactivity in the retina of macaque monkeys with experimental glaucoma does not identify vulnerable neurons

Experimental Neurology

Volumn 153, Issue 2, 1998, Pages 234-241

  Hof, Patrick R ^a   Lee, Ping Yu ^a   Yeung, Glendy ^a   Wang, Rong Fang ^a   Podos, Steven M ^a   Morrison, John H ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Excitotoxicity; Experimental glaucoma; Ganglion cells; Glutamate receptors; Retina; Selective vulnerability

Indexed keywords

GLUTAMATE RECEPTOR; RECEPTOR SUBUNIT;

ANIMAL CELL; ARTICLE; CELL VIABILITY; CELLULAR DISTRIBUTION; GLAUCOMA; IMMUNOREACTIVITY; MONKEY; NERVE CELL; NERVE DEGENERATION; NEUROFILAMENT; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RETINA AMACRINE CELL; RETINA CELL; TRABECULAR MESHWORK;

EID: 0032191965     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1998.6881     Document Type: Article

References (39)

1. Allison D. W., Gelfand V. I., Spector I., Craig A. M. Role of actin in anchoring postsynaptic receptors in cultured hippocampal neurons: Differential attachment of NMDA versus AMPA receptors. J. Neurosci. 18:1998;2423-2436.
2. Bloom F. E., Young W. G., Nimchinsky E. A., Hof P. R., Morrison J. H. Neuronal vulnerability and informatics in human disease. Progress in Neuroinformatics Research, Vol. 1, Neuroinformatics - An Overview of the Human Brain Project. 1997;Lawrence Erlbaum, Mahwah. p. 83-123.
3. Brandstätter J. H., Hartveit E., Sassoè-Pognetto M., Wässle H. Expression of NMDA and high-affinity kainate receptor subunit mRNAs in the adult rat retina. Eur. J. Neurosci. 6:1994;1100-1112.
4. Cazevieille C., Osborne N. N. Retinal neurones containing kainate receptors are influenced by exogenous kainate and ischaemia while neurones lacking these receptors are not - Melatonin counteracts the effect of ischaemia and kainate. Brain Res. 755:1997;91-100.
5. Dreyer E. B., Pan Z. H., Storm S., Lipton S. A. Greater sensitivity of larger retinal ganglion cells to NMDA-mediated cell death. NeuroReport. 5:1994;629-631.
6. Dreyer E. B., Zurakowski D., Schumer R. A., Podos S. M., Lipton S. A. Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch. Ophthalmol. 114:1996;299-305.
7. Ehlers M. D., Fung E. T., O'Brien R. J., Huganir R. L. Splice variant-specific interaction of the NMDA receptor subunit NR1 with neuronal intermediate filaments. J. Neurosci. 18:1998;720-730.
8. Freund T. F., Buszáki G., Leon A., Baimbridge K. G., Somogyi P. Relationship of neuronal vulnerability and calcium binding protein immunoreactivity in ischemia. Exp. Brain Res. 83:1990;55-66.
9. Glovinsky Y., Quigley H. A., Dunkelberger G. R. Retinal ganglion cell loss is size dependent in experimental glaucoma. Invest. Ophthalmol. Vis. Sci. 32:1991;484-491.
10. 2+. Trends Neurosci. 15:1992;259-264.
11. Hof P. R., Morrison J. H. The cellular basis of cortical disconnection in Alzheimer disease and related dementing conditions. Terry R. D., Katzman R., Bick K. L. Alzheimer Disease. 1994;197-229 Raven Press, New York.
12. Hollmann M., Heinemann S. F. Cloned glutamate receptors. Annu. Rev. Neurosci. 17:1994;31-108.
13. Hughes T. E., Hermans-Borgmeyer I., Heinemann S. Differential expression of glutamate receptor genes (GluR1-5) in the rat retina. Vis. Neurosci. 8:1992;49-55.
14. Jonas P., Racca C., Sakman B., Seeburg P. H., Monyer H. Differences in calcium permeability of AMPA type glutamate receptor channels in neocortical neurons caused by differential GluR B subunit expression. Neuron. 12:1994;1281-1289.
15. Lee P. Y., Podos S. M., Howard-Williams J. R., Séverin C. H., Rose A. D., Siegel M. J. Pharmacological testing in the laser-induced monkey glaucoma model. Curr. Eye Res. 4:1985;775-781.
16. Leranth C., Ribak C. E. Calcium-binding proteins are concentrated in the CA2 field of the monkey hippocampus: A possible key to this region's resistance to epileptic damage. Exp. Brain Res. 85:1991;129-136.
17. Lucas D. R., Newhouse J. P. The toxic effect of sodiumL. Am. Med. Assoc. Arch. Ophthalmol. 58:1957;193-201.
18. Lukas W., Jones K. A. Cortical neurons containing calretinin are selectively resistant to calcium overload and excitotoxicityin vitro. Neuroscience. 61:1994;307-316.
19. Michaelis E. K. Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and aging. Prog. Neurobiol. 54:1998;369-415.
20. Morrison B. M., Janssen W. G. M., Gordon J. W., Morrison J. H. Light and electron microscopic distribution of the AMPA receptor subunit, GluR2, in the spinal cord of control and G86R mutant superoxide dismutase transgenic mice. J. Comp. Neurol. 395:1998;523-534.
21. Morrison J. H., Hof P. R. Life and death of neurons in the aging brain. Science. 278:1997;412-419.
22. Olney J. W. Glutamate-induced retinal degeneration in neonatal mice. Electron microscopy of the acutely evolving lesion. J. Neuropathol. Exp. Neurol. 28:1969;455-474.
23. Otori Y., Wei J. Y., Barnstable C. J. Neurotoxic effects of low doses of glutamate on purified rat retinal ganglion cells. Invest. Ophthalmol. Vis. Sci. 39:1998;972-981.
24. Pellegrini-Giampietro D. E., Zukin R. S., Bennett M. V. L., Cho S., Pulsinelli W. A. Switch in glutamate receptor subunit gene expression in CA1 subfield of hippocampus following global ischemia in rats. Proc. Natl. Acad. Sci. USA. 89:1992;10499-10503.
25. Pellegrini-Giampietro D. E., Pulsinelli W. A., Zukin R. S. NMDA and non-NMDA receptor gene expression following global brain ischemia in rats: Effect of NMDA and non-NMDA receptor antagonists. J. Neurochem. 62:1994;1067-1073.
26. Pollard H., Héron A., Moreau J., Ben-Ari Y., Khrestchatisky M. Alterations of the GluR-B AMPA receptor subunit flip/flop expression in kainate-induced epilepsy and ischemia. Neuroscience. 57:1993;545-554.
27. Quigley H. A., Sanchez R. M., Dunkelberger G. R., L'Hernault N. L., Baginski T. A. Chronic glaucoma selectively damages large optic nerve fibers. Invest. Ophthalmol. Vis. Sci. 8:1987;913-920.
28. Schumer R. A., Podos S. M. The nerve of glaucoma. Arch. Ophthalmol. 112:1994;37-44.
29. Siegel S. J., Brose N., Janssen W. G., Gasic G. P., Jahn R., Heinemann S. F., Morrison J. H. Regional, cellular, and ultrastructural distribution ofND. Proc. Natl. Acad. Sci. USA. 91:1994;564-568.
30. Siliprandi R., Canella R., Carmignoto G., Schiavo N., Zanellato A., Zanoni R., Vantini G. N-methyl-D-aspartate-induced neurotoxicity in the adult rat retina. Vis. Neurosci. 8:1992;567-573.
31. Sisk D. R., Kubawara T. Histologic changes in the inner retina of albino rats following intravitreal injection of monosodiumL. Graefe's Arch. Clin. Exp. Ophthalmol. 223:1985;250-258.
32. Sisk D. R., Kubawara T., Kirsch A. D. Behavioral recovery in albino rats with glutamate-damaged retinas. Invest. Ophthalmol. Vis. Sci. 25:1984;1124-1128.
33. 28k. J. Comp. Neurol. 280:1989;183-196.
34. Sucher N. J., Aizenman E., Lipton S. A. NDin vitro. J. Neurosci. 11:1991;966-971.
35. Vickers J. C., Schumer R. A., Podos S. M., Wang R. F., Riederer B. M., Morrison J. H. Differential vulnerability of neurochemically identified subpopulations of retinal neurons in a monkey model of glaucoma. Brain Res. 680:1995;23-35.
36. Vissavajjhala P., Janssen W. G. M., Hu Y., Gazzaley A. H., Moran T., Hof P. R., Morrison J. H. Synaptic distribution of AMPA-GluR2 subunit and its colocalization with calcium-binding proteins in rat cerebral cortex: An immunohistochemical analysis using a GluR2-specific monoclonal antibody. Exp. Neurol. 142:1996;296-312.
37. Vorwerk C. K., Lipton S. A., Zurakowski D., Hyman B. T., Sabel B. A., Dreyer E. B. Chronic low-dose glutamate is toxic to retinal ganglion cells - Toxicity blocked by memantine. Invest. Ophthalmol. Vis. Sci. 37:1996;1618-1624.
38. Wang R. F., Schumer R. A., Serle J. B., Podos S. M. A comparison of Argon laser and diode laser photocoagulation of the trabecular meshwork to produce the glaucoma monkey model. J. Glaucoma. 7:1998;45-49.
39. Zurakowski D., Vorwerk C. K., Gorla M., Kanellopoulos A. J., Chaturvedi N., Grosskreutz C. L., Lipton S. A., Dreyer E. B. Nitrate therapy may retard glaucomatous optic neuropathy, perhaps through modulation of glutamate receptors. Vision Res. 38:1998;1489-1494.